Purchase Order 75N91020P00931

The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order valued at $22,500 to the University of Kansas Center for Research, Inc. This award is pursuant to a request for quote to develop a manufacturable tablet formulation of the compound NCGC72 for use in dog sarcoma clinical studies. The prime contractor will non-GMP manufacture 1,500 tablets total, with 1,000 tablets at 50mg dosage and 500 tablets at...

This is a $1,995,852.00 Firm Fixed Price SBIR Phase II contract awarded by the National Cancer Institute (NCI) to Avantgen Inc., a small business based in San Diego, California. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics" under Topic 372. The goal is to develop high-affinity, highly specific rabbit monoclonal antibodies against an expanded panel of 26 canine biomarkers to facilitate the use of dogs...

This federal contract award from the National Institutes of Health (NIH), National Cancer Institute (NCI), is for a Veterinary Clinical Trial Study to Test Combination Anti-Cancer Therapy for Dogs with Naturally Occurring Melanoma. The $334,395.10 firm-fixed-price delivery order was awarded to Guidehouse Digital LLC, a global consulting firm that provides specialized scientific, technical, and administrative support services to federal agencies. The contract has a completion date of March 24,...

This contract award, valued at $81,109.99, is for the performance of an "Anti-Cancer Drug Testing in Canine Sarcomas Study" by Guidehouse Digital LLC, a global consulting firm that provides management, technology, and risk consulting services to public and commercial sectors. The contract was awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services (HHS). This delivery order contract has a firm-fixed-price...

The National Institute of Health's National Cancer Institute awarded a delivery order to Guidehouse Digital LLC on November 13, 2023, under the Comparative Oncology Program for research titled "Repurposing Vaccine Immunity to Treat Cancers Validation in Canine Patients." This $442,912.30 time and materials contract, which is not set-aside, supports specialized services for the NCI's Center for Cancer Research and will be performed in Rockville, Maryland, with an ultimate completion...

This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $1,259,678.78 contract is to provide support for the preclinical development of an endoxifen gel, including pharmacology, toxicology, and safety studies to support an Investigational New Drug (IND) application. This contract is part of the NCI's PREVENT...

Societal Cdmo San Diego, LLC was awarded a $78,600 firm fixed price delivery order against the National Cancer Institute Cooperative Agreement for Cancer Target Discovery and Preclinical Validation Studies master indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health. Under the delivery order, Societal Cdmo San Diego, LLC will provide metarestin storage and stability testing services for the National Cancer Institute,...

This firm fixed-price purchase order for $86,631 was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Labcorp Early Development Laboratories Inc. to perform 60-month stability testing of two lots of LMB-100 drug product. LMB-100 is an anti-mesothelin immunotoxin under clinical trials for certain cancers. The prime contractor Labcorp will conduct a battery of assays to ensure the identity, potency, and safety of the drug product...

This is a delivery order awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute (NCI). The $3,323,184.00 cost-plus-fixed-fee contract is for longitudinal studies of dogs with cancer as a comparative oncology model. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for NCI, providing a range of biomedical research and facilities support services. This contract has no set-aside...

This is a delivery order under the Toxicology of Drugs Developed for Cancer Patients contract vehicle, awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute. The $248,269.21 cost-plus-fixed-fee contract is for a pre-clinical toxicity study to characterize the toxicity of potential anticancer compounds following multiple dose administration to rats. The contract runs from January 18, 2017 to June 30, 2018. No set-aside designation is mentioned. Battelle frequently serves...